Alyftrek

vanzacaftor, tezacaftor, and deutivacaftor

Approval

ApplicationNDA 218730
Approval dateDec 20, 2024
Approval year2024
SponsorVertex Pharms INC

FDA-approved use

For the treatment of cystic fibrosis (CF) in patients 6 years of age and older

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Alyftrek: